BVX — Bivictrix Therapeutics Share News
0.000.00%
- £10.73m
- £7.71m
REG - BiVictriX Therapcts. - Result of General Meeting
AnnouncementREG - BiVictriX Therapcts. - Result of Conditional Fundraise
AnnouncementREG - BiVictriX Therapcts. - Proposed Fundraise in excess of £2 million
AnnouncementREG - BiVictriX Therapcts. - Positive final data in preclinical efficacy study
AnnouncementREG - BiVictriX Therapcts. - Positive interim data
AnnouncementREG - BiVictriX Therapcts. - BiVictriX nominates clinical candidate for BVX001
AnnouncementREG - BiVictriX Therapcts. - Result of Annual General Meeting
AnnouncementREG - BiVictriX Therapcts. - Publication of Annual Report and Notice of AGM
AnnouncementREG - BiVictriX Therapcts. - BiVictriX Full Year Results
AnnouncementREG - BiVictriX Therapcts. - Appointment of Alex Hughes as CFO
AnnouncementREG - BiVictriX Therapcts. - BiVictriX reports positive BVX001 preclinical data
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - BiVictriX: Board Change
AnnouncementREG - BiVictriX Therapcts. - BiVictriX identifies lead for BVX001 programme
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
Announcement